Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immune Profiling for Cancer Immunotherapy Response
Sponsor: Dartmouth-Hitchcock Medical Center
Summary
In patients clinically treated with FDA-approved immunotherapy the investigators will assess the predictive value of pre- and on-treatment 1) immune-methylation profiling across cancer types, and 2) immune-methylation profiling and cytokine profiling within cancer types.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1500
Start Date
2022-10-03
Completion Date
2029-01-01
Last Updated
2025-12-16
Healthy Volunteers
No
Interventions
Methylation Cytometry
Assessment of the ability of Methylation Cytometry in pre-treatment peripheral blood and in repeated measures over the duration of treatment to predict treatment response or occurrence of adverse events.
Locations (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States